Literature DB >> 34087329

Role of extracellular vesicles in liver diseases and their therapeutic potential.

Enis Kostallari1, Shantha Valainathan2, Louise Biquard3, Vijay H Shah4, Pierre-Emmanuel Rautou5.   

Abstract

More than eight hundred million people worldwide have chronic liver disease, with two million deaths per year. Recurring liver injury results in fibrogenesis, progressing towards cirrhosis, for which there doesn't exists any cure except liver transplantation. Better understanding of the mechanisms leading to cirrhosis and its complications is needed to develop effective therapies. Extracellular vesicles (EVs) are released by cells and are important for cell-to-cell communication. EVs have been reported to be involved in homeostasis maintenance, as well as in liver diseases. In this review, we present current knowledge on the role of EVs in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis, alcohol-associated liver disease, chronic viral hepatitis, primary liver cancers, acute liver injury and liver regeneration. Moreover, therapeutic strategies involving EVs as targets or as tools to treat liver diseases are summarized.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cirrhosis; Exosomes; Fibrosis; Microvesicles; Portal hypertension; Steatosis

Mesh:

Year:  2021        PMID: 34087329     DOI: 10.1016/j.addr.2021.05.026

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  6 in total

Review 1.  Pathological Contribution of Extracellular Vesicles and Their MicroRNAs to Progression of Chronic Liver Disease.

Authors:  Chanbin Lee; Jinsol Han; Youngmi Jung
Journal:  Biology (Basel)       Date:  2022-04-21

2.  LncRNA-COX2 inhibits Fibroblast Activation and Epidural Fibrosis by Targeting EGR1.

Authors:  Lei Yang; Shengnai Zheng; Dawei Ge; Mingjie Xia; Haijun Li; Jian Tang
Journal:  Int J Biol Sci       Date:  2022-01-16       Impact factor: 6.580

3.  Editorial: Chronic Liver Disease: New Targets and New Mechanisms.

Authors:  Yanting Ye; Hua Wang; Jinhang Gao; Enis Kostallari
Journal:  Front Mol Biosci       Date:  2022-07-18

Review 4.  Review article: vascular effects of PPARs in the context of NASH.

Authors:  Sergi Guixé-Muntet; Louise Biquard; Gyongyi Szabo; Jean-François Dufour; Frank Tacke; Sven Francque; Pierre-Emmanuel Rautou; Jordi Gracia-Sancho
Journal:  Aliment Pharmacol Ther       Date:  2022-06-05       Impact factor: 9.524

Review 5.  Extracellular vesicles: A new diagnostic biomarker and targeted drug in osteosarcoma.

Authors:  Xiaozhuo Gao; Bo Gao; Shenglong Li
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

6.  Reduced Plasma Extracellular Vesicle CD5L Content in Patients With Acute-On-Chronic Liver Failure: Interplay With Specialized Pro-Resolving Lipid Mediators.

Authors:  María Belen Sánchez-Rodríguez; Érica Téllez; Mireia Casulleras; Francesc E Borràs; Vicente Arroyo; Joan Clària; Maria-Rosa Sarrias
Journal:  Front Immunol       Date:  2022-03-07       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.